Research Faculty

Hematology-Oncology Research Faculty

Choose a faculty member to view his or her research profile. Links go to the School of Medicine Research Faculty Directory; use the back button to return to the Hem/Onc division website.

Christiana Brenin

Brenin, Christiana M.

Breast cancer clinical trials for early stage and metastatic breast cancer in selected patient populations.

John Densmore

Densmore, John J.

Malignant hematology (lymphoma, myeloma, leukemia)

Patrick Dillon

Dillon, Patrick M.

Development of clinical trials in breast cancer; cancer immunotherapy; cancer survivorship improvement; cancer and aging.

Michael Douvas

Douvas, Michael G.

Clinical research in hematologic malignancies, fertility preservation, and quality improvement.

Robert Dreicer

Dreicer, Robert

Novel therapeutic approaches for urologic cancers including prostate, urothelial and kidney cancers.

David Feith

Feith, David

Cell signaling and survival pathways, genetic alterations, and development of experimental therapeutics; large granular lymphocyte (LGL) leukemia; acute myeloid leukemia (AML); role of polyamines in normal and neoplastic growth in the skin, upper aerodige

Tania Felizardo

Felizardo, Tania

T cell/Treg therapy; gene immunotherapy; cancer immunotherapy; mammalian target of rapamycin (mTOR)-signaling pathway

Francine Garrett-Bakelman

Garrett-Bakelman, Francine

Acute Myeloid Leukemia: molecular and cellular biology events which mediate aberrant epigenetic and transcriptional mechanisms during disease establishment and progression

Elizabeth Gaughan

Gaughan, Elizabeth M.

Melanoma, Head and Neck Cancer, Genitourinary malignancies, Drug development, Cancer Immunotherapy

Ryan Gentzler

Gentzler, Ryan D.

Lung cancer, novel therapies, cancer immunology, and targeted therapy

Richard Hall

Hall, Richard Delmar

Clinical trial design and development for novel therapeutics and immunotherapy for the treatment of lung cancer.

Michael Keng

Keng, Michael K

Clinical trials in hematologic malignancies, including myelodysplastic syndromes and leukemias with special interest in treating the elderly population, determining optimal combinations and timing of targeted agents in MDS and leukemia, and studying patie

Thomas Loughran, Jr.

Loughran, Jr., Thomas P

Hematologic malignancies; bone marrow disorders; leukemia; large granular lymphocyte (LGL)

Lawrence Lum

Lum, Lawrence G.

Cancer immunotherapy

Hillary Maitland

Maitland, Hillary S

Hemostasis and thrombosis

Craig Portell

Portell, Craig Anthony

Clinical trials in hematologic malignancies including leukemias and lymphomas, with special interest in determining optimal combinations and timing of targeted agents in B-cell leukemias and lymphomas.

Archana Thakur

Thakur, Archana

Dr. Thakur's research activities are focused on 1) developing new and innovative therapeutic approaches to enhance clinical and anti-tumor immune responses; 2) developing novel strategies to attenuate the immune suppressive cellular and humoral factors.

Leonid Volodin

Volodin, Leonid

Reduced intensity conditioning use, pre-transplant co-morbidity assessment.

Michael Williams

Williams, Michael E.

Dr. Williams’ research interests include clinical trials and translational science for mantle cell lymphoma, other non-Hodgkin lymphomas and CLL, with a focus on targeted agents and immuno-therapeutics. He was a co-investigator on three pivotal clinical trials that led to FDA approvals in B-cell lymphoma. The current focus of the Lymphoma and Leukemia Research Team is to improve treatment response and cure via novel combinations of targeted therapeutic agents and to optimize anti-lymphoma immunotherapy.

No Photo Available

Yang, Jun